Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 17, 2022
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
Tue, August 16, 2022
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
Carter Gould Maintained (APLT) at Hold with Decreased Target to $2.25 on, Aug 16th, 2022
Carter Gould of Barclays, Maintained "Applied Therapeutics, Inc." (APLT) at Hold with Decreased Target from $2.5 to $2.25 on, Aug 16th, 2022.
Carter has made no other calls on APLT in the last 4 months.
There is 1 other peer that has a rating on APLT. Out of the 1 peers that are also analyzing APLT, 0 agree with Carter's Rating of Hold.
This is the rating of the analyst that currently disagrees with Carter
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $29 on, Friday, May 20th, 2022
